Secondary reactive oxygen species production after PDT during pulmonary tumor growth in sera of nude mice

Photodiagnosis and Photodynamic Therapy

Volumn 10, Issue 1, 2013, Pages 62-71

  Douillard, Samuel ^a   Rozec, Bertrand ^a   Bigot, Edith ^a   Aillet, Lorena ^a   Patrice, Thierry ^a  

^a CHU de Nantes   (France)

Author keywords

Dichlorofluorescein; Hemolysis; Oxidative stress; Reactive oxygen species (ROS); Serum; Singlet oxygen; Total antioxidant status

Indexed keywords

CHOLESTEROL; REACTIVE OXYGEN METABOLITE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CANCER GRAFT; CONTROLLED STUDY; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; SINGLET OXYGEN; SPECIES SPECIFICITY; TREATMENT OUTCOME;

MUS; MUS MUSCULUS;

EID: 84875395306     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2012.05.004     Document Type: Article

References (56)

1. Weishaupt K.R., Gomer C.J., Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Research 1976, 36:2326-2329.
2. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. Journal of Photochemistry and Photobiology B 1997, 39:1-18.
3. Hariharan P.V., Courtney J., Eleczko S. Production of hydroxyl radicals in cell systems exposed to haematoporphyrin and red light. International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine 1980, 37:691-694.
4. Kon T., Tanigawa T., Hayamizu K., et al. Singlet oxygen quenching activity of human serum. Redox Report 2004, 9:325-330.
5. Tanielian C., Mechin R., Seghrouchni R., Schweitzer C. Mechanistic and kinetic aspects of photosensitization in the presence of oxygen. Photochemistry and Photobiology 2000, 71:12-19.
6. Wright A., Hawkins C.L., Davies M.J. Photo-oxidation of cells generates long-lived intracellular protein peroxides. Free Radical Biology and Medicine 2003, 34:637-647.
7. Girotti A.W. Translocation as a means of disseminating lipid hydroperoxide-induced oxidative damage and effector action. Free Radical Biology and Medicine 2008, 44:956-968.
8. Kessel D., Luo Y. Delayed oxidative photodamage induced by photodynamic therapy. Photochemistry and Photobiology 1996, 64:601-604.
9. Olivier D., Douillard S., Lhommeau I., Patrice T. Photodynamic treatment of culture medium containing serum induces long-lasting toxicity in vitro. Radiation Research 2009, 172:451-462.
10. Chakraborty A., Held K.D., Prise K.M., Liber H.L., Redmond R.W. Bystander effects induced by diffusing mediators after photodynamic stress. Radiation Research 2009, 172:74-81.
11. Seshadri M., Bellnier D.A., Vaughan L.A., et al. Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clinical Cancer Research 2008, 14:2796-2805.
12. Foultier M.T., Vonarx-Coinsman V., de Brito L.X., Morlet L., Robillard N., Patrice T. DNA or cell kinetics flow cytometry analysis of 33 small gastrointestinal cancers treated by photodynamic therapy. Cancer 1994, 73:1595-1607.
13. Casas A., Di Venosa G., Vanzulli S., et al. Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy. Cancer Letters 2008, 271:342-351.
14. Busch T.M. Hypoxia and perfusion labeling during photodynamic therapy. Methods in Molecular Biology 2010, 635:107-120.
15. Edell E.S., Cortese D.A. Bronchoscopic localization and treatment of occult lung cancer. Chest 1989, 96:919-921.
16. Jerjes W., Upile T., Betz C.S., et al. The application of photodynamic therapy in the head and neck. Dental Update 2007, 34. p. 478-80, 83-4, 86.
17. Sutedja T.G. Photodynamic therapy in advanced tracheobronchial cancers. Diagnostic and Therapeutic Endoscopy 1999, 5:245-251.
18. Moghissi K., Dixon K., Stringer M., Freeman T., Thorpe A., Brown S. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. European Journal of Cardio-Thoracic Surgery 1999, 15:1-6.
19. Allison R., Moghissi K., Downie G., Dixon K. Photodynamic therapy (PDT) for lung cancer. Photodiagnosis and Photodynamic Therapy 2011, 8:231-239.
20. Olivier D., Douillard S., Lhommeau I., Bigot E., Patrice T. Secondary oxidants in human serum exposed to singlet oxygen: the influence of hemolysis. Photochemical and Photobiological Sciences 2009, 8:1476-1486.
21. Acharya A., Das I., Chandhok D., Saha T. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxidative Medicine and Cellular Longevity 2009, 3:23-34.
22. Oyagbemi A.A., Azeez O.I., Saba A.B. Interactions between reactive oxygen species and cancer: the roles of natural dietary antioxidants and their molecular mechanisms of action. The Asian Pacific Journal of Cancer Prevention 2009, 10:535-544.
23. Houghton A.M. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle 2010, 9:1732-1737.
24. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998, 92:3007-3017.
25. Badwey J.A., Karnovsky M.L. Active oxygen species and the functions of phagocytic leukocytes. Annual Review of Biochemistry 1980, 49:695-726.
26. Kanofsky J.R., Hoogland H., Wever R., Weiss S.J. Singlet oxygen production by human eosinophils. Journal of Biological Chemistry 1988, 263:9692-9696.
27. Kanofsky J.R. Singlet oxygen production by biological systems. Chemico-Biological Interactions 1989, 70:1-28.
28. Lhommeau I., Douillard S., Bigot E., Benoit I., Krempf M., Patrice T. Serum resistance to singlet oxygen in patients with diabetes mellitus in comparison to healthy donors. Metabolism: Clinical and Experimental 2011, 60:1340-1348.
29. Bourre L., Simonneaux G., Ferrand Y., Thibaut S., Lajat Y., Patrice T. Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy. Journal of Photochemistry and Photobiology B 2003, 69:179-192.
30. Doki Y., Murakami K., Yamaura T., Sugiyama S., Misaki T., Saiki I. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice. British Journal of Cancer 1999, 79:1121-1126.
31. Weiss J., Taylor G., Zimmermann F., Nebendahl K. Collection of body fluids. The laboratory rat 2000, 485-510. Academic Press, London. 2000th ed. G. Krinke (Ed.).
32. Redmond R.W., Gamlin J.N. A compilation of singlet oxygen yields from biologically relevant molecules. Photochemistry and Photobiology 1999, 70:391-475.
33. Harrison S.D., Burdeshaw J.A., Crosby R.G., Cusic A.M., Denine E.P. Hematology and clinical chemistry reference values for C57BL/6 X DBA/2 F1 mice. Cancer Research 1978, 38:2636-2639.
34. Fernandez I., Pena A., Del Teso N., Perez V., Rodriguez-Cuesta J. Clinical biochemistry parameters in C57BL/6J mice after blood collection from the submandibular vein and retroorbital plexus. Journal of the American Association for Laboratory Animal Science 2010, 49:202-206.
35. Moghissi K., Dixon K., Thorpe J.A., Stringer M., Oxtoby C. Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. Thorax 2007, 62:391-395.
36. Sotgia F., Martinez-Outschoorn U.E., Lisanti M.P. Mitochondrial oxidative stress drives tumor progression metastasis: should we use antioxidants as a key component of cancer treatment and prevention?. BMC Medicine 2011, 9:62.
37. Nowis D., Legat M., Grzela T., et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006, 25:3365-3374.
38. Wagener F.A., Eggert A., Boerman O.C., et al. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 2001, 98:1802-1811.
39. Wagener F.A., Volk H.D., Willis D., et al. Different faces of the heme-heme oxygenase system in inflammation. Pharmacological Reviews 2003, 55:551-571.
40. Waring W.S., Mishra V., Maxwell S.R. Comparison of spectrophotometric and enhanced chemiluminescent assays of serum antioxidant capacity. Clinica Chimica Acta 2003, 338:67-71.
41. Tsimikas S. Measures of oxidative stress. Clinics in Laboratory Medicine 2006, 26(v-vi):571-590.
42. Miller A.C., Henderson B.W. The influence of cellular glutathione content on cell survival following photodynamic treatment in vitro. Radiation Research 1986, 107:83-94.
43. Bartosz G. Non-enzymatic antioxidant capacity assays: limitations of use in biomedicine. Free Radical Research 2010, 44:711-720.
44. Hafer K., Iwamoto K.S., Schiestl R.H. Refinement of the dichlorofluorescein assay for flow cytometric measurement of reactive oxygen species in irradiated and bystander cell populations. Radiation Research 2008, 169:460-468.
45. Esposito L., Conti D., Ailavajhala R., Khalil N., Giordano A., Lung Cancer: Are we up to the challenge?. Current Genomics 2010, 11:513-518.
46. Nanguzgambo A.B., Aubeelack K., von Groote-Bidlingmaier F., et al. Radiologic features, staging, and operability of primary lung cancer in the Western cape, South Africa: a 1-year retrospective study. Journal of Thoracic Oncology 2011, 6:343-350.
47. Editorial: operability of lung cancer. British Medical Journal 1975, 2:299.
48. Bignall J.R., Martin M. Survival experience of women with bronchial carcinoma. Lancet 1972, 2:60-62.
49. Ninfali P., Aluigi G. Variability of oxygen radical absorbance capacity (ORAC) in different animal species. Free Radical Research 1998, 29:399-408.
50. Hileman E.O., Liu J., Albitar M., Keating M.J., Huang P. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemotherapy and Pharmacology 2004, 53:209-219.
51. Andersen H.R., Nielsen J.B., Nielsen F., Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clinical Chemistry 1997, 43:562-568.
52. Crawford D.R., Davies K.J. Adaptive response and oxidative stress. Environmental Health Perspectives 1994, 102(Suppl. 10):25-28.
53. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P., Vitamin E supplementation and cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators. New England Journal of Medicine 2000, 342:154-160.
54. Douillard S., Lhommeau I., Foursac A., Aillet L., Bigot E., Patrice T. Biophysical parameters influencing secondary oxidants activation in human serum exposed to singlet oxygen. Journal of Photochemistry and Photobiology B 2010, 102:224-231.
55. Buck M., Zhang L., Halasz N.A., Hunter T., Chojkier M. Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha. EMBO Journal 2001, 20:6712-6723.
56. Henderson B.W., Gollnick S.O., Snyder J.W., et al. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Research 2004, 64:2120-2126.